BMI1 and glioblastoma: To dissect the pioneer molecular changes resulting from BMI1 inactivation, we targeted BMI1 exon 1 using CRISPR/Cas9 technology to generate BMI1 knockout (BMI1KO) GBM cells.48 A non-targeting template guide RNA was used as a negative control.